OpenAlex
PricingAboutJobs
Log inGet started
Work

The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.

PubMed

Year: 2003
Type: article
Source: PubMed
Authors: Simona Gatto, Barbara Scappini, Lan Pham, Francesco Onida, Michele Milella, Greg Ball, Clara Ricci, Vladimir Divoky, Srdan Verstovsek, Hagop M Kantarjian, Michael J Keating, Jorge E Cortes-Franco, Miloslav Beran
Institutions: The University of Texas MD Anderson Cancer Center, Institut für Hämatopathologie Hamburg, Houston Methodist, Palacký University Olomouc
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: bortezomib, imatinib mesylate, BCR-ABL, chronic myeloid leukemia, imatinib resistance, apoptosis, proteasome inhibitors, NF-κB, Bcl-xL, caspase-3, G2/M cell cycle arrest, combination therapy, synergistic and antagonistic effects
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2181574800
FWCI: 3.924
Cites: 39
Cited by: 84
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms